Close
Nordic 9Nordic 9

Janus Henderson (investor - Private Equity)

United States
See something wrong or missing? Let us know
Offices:New York
Average round investment:78.61M USD
Average number per year:2.0
Distribution: 2025 (2)
Portfolio companies: United Kingdom Artios PharmaGermany Tubulis
Mostly invests in: United Kingdom United Kingdom (1) Health services (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Janus Henderson

Name Criteria
United States Prime Movers Labs
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States HOF Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Italy XGEN Venture
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Elevage Medical Technologies
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Switzerland HBM Healthcare Investments
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Spain Mutua Madrileña
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Switzerland Mirabaud Asset Management
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United States Samsara BioCapital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Redmile Group
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Avego Bioscience Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Top